Navigation Links
Shire plc: Change to Director's Details
Date:2/5/2009

PHILADELPHIA and DUBLIN, February 5 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that Mr Matthew Emmens, non-executive Chairman of Shire, has been appointed President of Vertex Pharmaceuticals Incorporated with immediate effect and that Mr Emmens will in addition become Chairman and Chief Executive Officer of Vertex in May 2009 when the current Chief Executive Officer retires.

    This announcement is made pursuant to Listing Rule 9.6.14R.

    Tony Guthrie
    Deputy Company Secretary


    Notes to editors
    Shire plc

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

    For further information please contact:

    Investor Relations
    Clea Rosenfeld (Rest of the World)
    +44-1256-894-160

    Eric Rojas (North America)
    +1-617-551-9715

    Media
    Matthew Cabrey (Specialty Pharma)
    +1-484-595-8248

    Jessica Cotrone (HGT)
    +1-617-613-4640

'/>"/>
SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1

Related biology technology :

1. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
2. Shires New Product Portfolio Delivers Strong Quarterly Performance
3. Change of Name to Shire plc
4. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
5. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
6. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
7. Shire Ltd.: Robin Buchanan to Step Down as Non-Executive Director on Completion of Term of Office
8. Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008
9. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
10. Application for Listing of Shire Limited Ordinary Shares
11. Shire Launches Nationwide Adult ADHD Mobile Awareness Tour
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... (PRWEB) May 21, 2013 Grace ... specializing in “game-changing” life science and health related private ... Dergham to its International Project Team. Dergham's expertise in ... greater multi-cultural depth to Grace Century as it continues ... globe. , Ms. Dergham holds both an under graduate ...
(Date:5/20/2013)... May 20, 2013  (PSHR) Pacific Shore Holdings, ... products across a broad range of product categories ... investor relations firm, BlueWater Advisory Group, to provide ... trading process, and to direct the company,s outreach ... Matthew Mills , Pacific ...
(Date:5/20/2013)... ROCKVILLE , Md. and BALTIMORE ... Inc. (BHI), a regional private-public partnership focusing ... to early-stage funding in Central Maryland ... Aiyar, Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) ... (NIH) National Heart, Lung and Blood Institute ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his colleagues ... Institute have helped pioneer many breakthroughs in the ... the past three decades, from new disease-fighting medications to ... stent implantation. , Today, AGH officials announced that the ... the study of a novel, first-of-its kind investigational device ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
... to support regulatory filings for S0812 and additional ... Senomyx, Inc. (Nasdaq: SNMX ), ... to discover and develop novel flavor ingredients for ... today that it has initiated development activities for ...
... 9 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology,International, Inc. (OTC Bulletin ... producer and distributor of nutrients for plants and,animals, ... announced that the,Company,s management will present at the ... Dana Point, California. , ...
... Shire plc (LSE: SHP, NASDAQ: SHPGY ), ... Barr Laboratories, Inc.,("Barr) and Mylan, Inc. ("Mylan) dated 2 ... the filing of an Abbreviated New Drug Application,("ANDA") for ... carbonate). , FOSRENOL is protected ...
Cached Biology Technology:SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 2SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 3SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 4Yongye Biotechnology to Present at Roth Conference 2Yongye Biotechnology to Present at Roth Conference 3Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... method for delivering molecules into single, targeted cells ... technique could find applications in drug delivery, cell ... a technique used to deliver molecules into ... that are caused by exposing them to electric ... cell transfection. (Cell transfection is the introduction of ...
(Date:5/21/2013)... ARBORThe new University of Michigan Water Center today ... support Great Lakes restoration and protection efforts. , ... support diverse projects, including efforts to track the ... of techniques to control non-native weedy plant invasions; ... monitor fish responses to restoration activities. , The ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... landmass now submerged beneath the Persian Gulf may have been ... according to an article published today in Current ... the University of Birmingham in the U.K., says that the ... been host to humans for over 100,000 years before it ...
... technology, reproductive scientists in Texas, led by Dr. Richard ... produced male and female mice from two fathers. ... the online site of the journal Biology of ... in a species of mammal could be a step ...
... the Max Planck Institute for Marine Microbiology in ... (M.I.T.) in Cambridge, Massachusetts have found a remarkable ... could affect the way scientists assess global carbon ... material and debris clumped together forming porous particles ...
Cached Biology News:Lost civilization under Persian Gulf? 2Reproductive scientists create mice from 2 fathers 2Sinking organic materials produce carbon dioxide 2
P8B1...
Goat polyclonal to Sarcosine Oxidase ( Abpromise for all tested applications). Antigen: Microbial Sarcosine Oxidase. Entrez Gene ID: 51268 Swiss Protein ID: Q6IAJ9...
Rabbit polyclonal to XPC ( Abpromise for all tested applications). Antigen: Synthetic peptide from N-terminus of Human XPC conjugated to a carrier protein Entrez Gene ID: 7508 Swiss ...
Rabbit polyclonal to FANCG ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSRQTTSVGSSC, corresponding to amino acids 1 - 12 of Human FANCG. Entrez GeneID: 2189 Swis...
Biology Products: